CAT NO. | LD-011007 |
CAS NO. | Dabrafenib Impurity 2 |
M.F. | C23H20F3N5O3S2 |
M.W. | 535.56 |
ADD TO CART |
CAT NO. | LD-011008 |
CAS NO. | Dabrafenib Impurity 3 |
M.F. | C23H18F3N5O4S2 |
M.W. | 549.54 |
ADD TO CART |
CAT NO. | LD-011009 |
CAS NO. | Dabrafenib Impurity 4 |
M.F. | C22H18F3N5O2S2 |
M.W. | 505.53 |
ADD TO CART |
CAT NO. | LD-011010 |
CAS NO. | N/A |
M.F. | C20H12F5NO6S2 |
M.W. | 521.43 |
ADD TO CART |
CAT NO. | LD-011011 |
CAS NO. | N/A |
M.F. | C18H13F3N4O3S |
M.W. | 422.38 |
ADD TO CART |
CAT NO. | LD-011012 |
CAS NO. | N/A |
M.F. | C23H22F2N6O2S2 |
M.W. | 516.59 |
ADD TO CART |
CAT NO. | LD-011013 |
CAS NO. | N/A |
M.F. | C23H22ClF3N4O2S2 |
M.W. | 543.02 |
ADD TO CART |
CAT NO. | LD-011014 |
CAS NO. | N/A |
M.F. | C23H21F2N5O2S2 |
M.W. | 501.57 |
ADD TO CART |
CAT NO. | LD-011015 |
CAS NO. | Dabrafenib Impurity 10 |
M.F. | C23H22F2N6O2S2 |
M.W. | 516.59 |
ADD TO CART |
CAT NO. | LD-011016 |
CAS NO. | Dabrafenib Impurity 11 |
M.F. | C22H16F3N5O5S2 |
M.W. | 551.52 |
ADD TO CART |
CAT NO. | LD-011017 |
CAS NO. | Dabrafenib Impurity 12 |
M.F. | C22H16F3N5O2S2 |
M.W. | 503.52 |
ADD TO CART |
CAT NO. | LD-011018 |
CAS NO. | N/A |
M.F. | C28H24F3N5O9S2 |
M.W. | 695.64 |
ADD TO CART |
CAT NO. | LD-011019 |
CAS NO. | N/A |
M.F. | C22H16F3N5O3S2 |
M.W. | 519.52 |
ADD TO CART |
CAT NO. | LD-011020 |
CAS NO. | Dabrafenib Impurity 15 |
M.F. | C6H4F2O3S |
M.W. | 194.15 |
ADD TO CART |
CAT NO. | LD-011021 |
CAS NO. | N/A |
M.F. | C14H11F2NO5S |
M.W. | 343.3 |
ADD TO CART |
CAT NO. | LD-011022 |
CAS NO. | N/A |
M.F. | C23H19F3N4O3S2 |
M.W. | 520.55 |
ADD TO CART |
CAT NO. | LD-011023 |
CAS NO. | N/A |
M.F. | C18H12F3N3O4S |
M.W. | 423.37 |
ADD TO CART |
CAT NO. | LD-011024 |
CAS NO. | Dabrafenib Impurity 19 |
M.F. | C6H3F3O2S |
M.W. | 196.14 |
ADD TO CART |
CAT NO. | LD-011025 |
CAS NO. | N/A |
M.F. | C23H21F3N4O4S2 |
M.W. | 538.56 |
ADD TO CART |
CAT NO. | LD-011026 |
CAS NO. | N/A |
M.F. | C23H20ClF3N4O3S2 |
M.W. | 557 |
ADD TO CART |
CAT NO. | LD-011027 |
CAS NO. | Dabrafenib Impurity 22 |
M.F. | C23H18ClF3N4O2S2 |
M.W. | 538.99 |
ADD TO CART |
CAT NO. | LD-011028 |
CAS NO. | Dabrafenib Impurity 23 |
M.F. | C5H5ClN2 |
M.W. | 128.56 |
ADD TO CART |
CAT NO. | LD-011029 |
CAS NO. | Dabrafenib Impurity 24 |
M.F. | C5H11NS |
M.W. | 117.21 |
ADD TO CART |
CAT NO. | LD-011030 |
CAS NO. | Diphemanil Methylsulfate |
M.F. | C20H24N. CH3O4S |
M.W. | 278.42 111.10 |
ADD TO CART |
CAT NO. | LD-011031 |
CAS NO. | Dosulepin EP Impurity E |
M.F. | C19H21NS |
M.W. | 295.45 |
ADD TO CART |
CAT NO. | LD-011032 |
CAS NO. | Dosulepin EP Impurity C |
M.F. | C19H23NOS |
M.W. | 313.47 |
ADD TO CART |
CAT NO. | LD-011033 |
CAS NO. | 33301-24-5 |
M.F. | C19H21NO2S |
M.W. | 327.45 |
ADD TO CART |
CAT NO. | LD-011034 |
CAS NO. | 897-15-4 |
M.F. | C19H21NS . HCl |
M.W. | 295.45 36.46 |
ADD TO CART |
CAT NO. | LD-011035 |
CAS NO. | 1447-71-8 |
M.F. | C19H21NOS |
M.W. | 311.45 |
ADD TO CART |
CAT NO. | LD-011036 |
CAS NO. | 1188266-11-6 |
M.F. | C18H16D3NOS. HCl |
M.W. | 300.43 36.46 |
ADD TO CART |
CAT NO. | LD-011007 |
CAS NO. | Dabrafenib Impurity 2 |
M.F. | C23H20F3N5O3S2 |
M.W. | 535.56 |
ADD TO CART |
CAT NO. | LD-011008 |
CAS NO. | Dabrafenib Impurity 3 |
M.F. | C23H18F3N5O4S2 |
M.W. | 549.54 |
ADD TO CART |
CAT NO. | LD-011009 |
CAS NO. | Dabrafenib Impurity 4 |
M.F. | C22H18F3N5O2S2 |
M.W. | 505.53 |
ADD TO CART |
CAT NO. | LD-011010 |
CAS NO. | N/A |
M.F. | C20H12F5NO6S2 |
M.W. | 521.43 |
ADD TO CART |
CAT NO. | LD-011011 |
CAS NO. | N/A |
M.F. | C18H13F3N4O3S |
M.W. | 422.38 |
ADD TO CART |
CAT NO. | LD-011012 |
CAS NO. | N/A |
M.F. | C23H22F2N6O2S2 |
M.W. | 516.59 |
ADD TO CART |
CAT NO. | LD-011013 |
CAS NO. | N/A |
M.F. | C23H22ClF3N4O2S2 |
M.W. | 543.02 |
ADD TO CART |
CAT NO. | LD-011014 |
CAS NO. | N/A |
M.F. | C23H21F2N5O2S2 |
M.W. | 501.57 |
ADD TO CART |
CAT NO. | LD-011015 |
CAS NO. | Dabrafenib Impurity 10 |
M.F. | C23H22F2N6O2S2 |
M.W. | 516.59 |
ADD TO CART |
CAT NO. | LD-011016 |
CAS NO. | Dabrafenib Impurity 11 |
M.F. | C22H16F3N5O5S2 |
M.W. | 551.52 |
ADD TO CART |
CAT NO. | LD-011017 |
CAS NO. | Dabrafenib Impurity 12 |
M.F. | C22H16F3N5O2S2 |
M.W. | 503.52 |
ADD TO CART |
CAT NO. | LD-011018 |
CAS NO. | N/A |
M.F. | C28H24F3N5O9S2 |
M.W. | 695.64 |
ADD TO CART |
CAT NO. | LD-011019 |
CAS NO. | N/A |
M.F. | C22H16F3N5O3S2 |
M.W. | 519.52 |
ADD TO CART |
CAT NO. | LD-011020 |
CAS NO. | Dabrafenib Impurity 15 |
M.F. | C6H4F2O3S |
M.W. | 194.15 |
ADD TO CART |
CAT NO. | LD-011021 |
CAS NO. | N/A |
M.F. | C14H11F2NO5S |
M.W. | 343.3 |
ADD TO CART |
CAT NO. | LD-011022 |
CAS NO. | N/A |
M.F. | C23H19F3N4O3S2 |
M.W. | 520.55 |
ADD TO CART |
CAT NO. | LD-011023 |
CAS NO. | N/A |
M.F. | C18H12F3N3O4S |
M.W. | 423.37 |
ADD TO CART |
CAT NO. | LD-011024 |
CAS NO. | Dabrafenib Impurity 19 |
M.F. | C6H3F3O2S |
M.W. | 196.14 |
ADD TO CART |
CAT NO. | LD-011025 |
CAS NO. | N/A |
M.F. | C23H21F3N4O4S2 |
M.W. | 538.56 |
ADD TO CART |
CAT NO. | LD-011026 |
CAS NO. | N/A |
M.F. | C23H20ClF3N4O3S2 |
M.W. | 557 |
ADD TO CART |
CAT NO. | LD-011027 |
CAS NO. | Dabrafenib Impurity 22 |
M.F. | C23H18ClF3N4O2S2 |
M.W. | 538.99 |
ADD TO CART |
CAT NO. | LD-011028 |
CAS NO. | Dabrafenib Impurity 23 |
M.F. | C5H5ClN2 |
M.W. | 128.56 |
ADD TO CART |
CAT NO. | LD-011029 |
CAS NO. | Dabrafenib Impurity 24 |
M.F. | C5H11NS |
M.W. | 117.21 |
ADD TO CART |
CAT NO. | LD-011030 |
CAS NO. | Diphemanil Methylsulfate |
M.F. | C20H24N. CH3O4S |
M.W. | 278.42 111.10 |
ADD TO CART |
CAT NO. | LD-011031 |
CAS NO. | Dosulepin EP Impurity E |
M.F. | C19H21NS |
M.W. | 295.45 |
ADD TO CART |
CAT NO. | LD-011032 |
CAS NO. | Dosulepin EP Impurity C |
M.F. | C19H23NOS |
M.W. | 313.47 |
ADD TO CART |
CAT NO. | LD-011033 |
CAS NO. | 33301-24-5 |
M.F. | C19H21NO2S |
M.W. | 327.45 |
ADD TO CART |
CAT NO. | LD-011034 |
CAS NO. | 897-15-4 |
M.F. | C19H21NS . HCl |
M.W. | 295.45 36.46 |
ADD TO CART |
CAT NO. | LD-011035 |
CAS NO. | 1447-71-8 |
M.F. | C19H21NOS |
M.W. | 311.45 |
ADD TO CART |
CAT NO. | LD-011036 |
CAS NO. | 1188266-11-6 |
M.F. | C18H16D3NOS. HCl |
M.W. | 300.43 36.46 |
ADD TO CART |
LEIDING
Create quality brand, cast first-class corporate image
Copyright © 2024 LeiDing All Rights Reserved.